Ian F. Tannock
Ontario Institute for Cancer Research(CA)University Health Network(CA)University of Toronto(CA)Princess Margaret Cancer Centre(CA)CancerCare(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Statistical Methods in Clinical Trials, Health Systems, Economic Evaluations, Quality of Life, Cancer-related cognitive impairment studies, Prostate Cancer Diagnosis and Treatment
Most-Cited Works
- → Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer(2004)5,695 cited
- → Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis(2014)3,162 cited
- → Drug penetration in solid tumours(2006)2,726 cited
- → Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group(2008)2,225 cited
- → Drug Resistance and the Solid Tumor Microenvironment(2007)2,087 cited
- → Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial(2014)1,763 cited